CA1292991C - Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires - Google Patents

Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires

Info

Publication number
CA1292991C
CA1292991C CA000510325A CA510325A CA1292991C CA 1292991 C CA1292991 C CA 1292991C CA 000510325 A CA000510325 A CA 000510325A CA 510325 A CA510325 A CA 510325A CA 1292991 C CA1292991 C CA 1292991C
Authority
CA
Canada
Prior art keywords
methyl
pyridine
alkyl
carboxylate
nitrophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000510325A
Other languages
English (en)
Inventor
Motohiko Ueda
Yoshiharu Hiramatsu
Ikuo Adachi
Masaru Kawakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to CA000510325A priority Critical patent/CA1292991C/fr
Application granted granted Critical
Publication of CA1292991C publication Critical patent/CA1292991C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA000510325A 1986-05-29 1986-05-29 Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires Expired - Fee Related CA1292991C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000510325A CA1292991C (fr) 1986-05-29 1986-05-29 Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000510325A CA1292991C (fr) 1986-05-29 1986-05-29 Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires

Publications (1)

Publication Number Publication Date
CA1292991C true CA1292991C (fr) 1991-12-10

Family

ID=4133237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000510325A Expired - Fee Related CA1292991C (fr) 1986-05-29 1986-05-29 Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires

Country Status (1)

Country Link
CA (1) CA1292991C (fr)

Similar Documents

Publication Publication Date Title
EP0354583B1 (fr) Dérivés du DC-88A
KR101943788B1 (ko) 치환된 5-플루오로-1h-피라졸로피리딘의 제조 방법
US8487101B2 (en) Thieno-pyridine derivatives as MEK inhibitors
CA2053601A1 (fr) Agents antimicrobiens ainsi que derives de 2-cyclohexan-1-yl-amine a substituant; leur obtention
UA81808C2 (en) Normal;heading 1;heading 2;DERIVATIVES OF PIPERIDINYL- AND PIPERAZINYL-ALKYL CARBAMATES, PROCESS FOR PREPARATION AND THERAPEUTIC USES THEREOF
KR20050099525A (ko) 피롤로트리아진 키나제 억제제의 제조 방법
CN116987112A (zh) 制备氨基嘧啶衍生物的改善方法
US11220489B2 (en) Process for preparing indole carboxamide compounds
CN103965133B (zh) 一种具有dhodh抑制活性的含n、s杂环化合物及其制备和用途
EP0207345B1 (fr) Dérivés de la 4,7-dihydrothiéno[2,3-b]pyridine, leur procédé de préparation et agents pour maladies cardiovasculaires
ES2635037T3 (es) Proceso para la preparación y purificación de apixaban
US6803467B2 (en) Intermediates for the production of quinolone carboxylic acid derivatives
KR100251522B1 (ko) 할로알콕시기를 함유하는 피롤[3,2-c]퀴놀린 유도체 및 약학적으로 허용되는 그의 염
US5214065A (en) Dc-89 derivatives
CA1292991C (fr) Derives de la 4,7-dihydrothieno[2,3-b]pyridine; methode pour les preparer et leur utilisation pour le traitement des maladies cardiovasculaires
AU649331B2 (en) Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments
EP0812838A1 (fr) Derive d'acide pyridonecarboxylique substitue par un groupe amino bicyclique, ester et sel de celui-ci, et amine bicyclique utilisee en tant qu'intermediaire pour celui-ci
CA2084162A1 (fr) Quinolylmethoxypenylacetamides
HU202506B (en) Process for producing benzoxazolone derivatives
US5248692A (en) DC-89 derivatives as anti-tumor agents
CN115806555B (zh) Indoloazepinone衍生物及其制备和在防治植物病毒、杀虫、杀菌的应用
US4677098A (en) Substituted dihydro-1H-pyrolizine-3,5(2H,6H)-diones
EP0443513B1 (fr) Composés azoxy
HU201516B (en) Process for producing 2-cyano-2-oximinoacetamide derivatives
WO1997010245A1 (fr) 2-[2-[(2-HYDROXYETHYL)AMINO]ETHYL]-5-[[2-METHYLAMINO)-ETHYL]AMINO]INDAZOLO[4,3-gh]ISOQUINOLIN-6(2H)-ONE UTILISE EN TANT QU'AGENT ANTITUMORAL

Legal Events

Date Code Title Description
MKLA Lapsed